Evidence map›Paper›PMID 38376141›Full record

ArticleeLife2024

Disordered regions and folded modules in CAF-1 promote histone deposition in

Fouad Ouasti, Maxime Audin, Karine Fréon, Jean-Pierre Quivy, Mehdi Tachekort, Elizabeth Cesard, Aurélien Thureau, Virginie Ropars, Paloma Fernández Varela, Gwenaelle Moal and 8 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Acute multi-level response to defectivebioRxiv : the preprint server for biology · 2024
    Article
  6. A marker-free genome editing method inmicroPublication biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Fouad Ouasti *Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, Gif-sur-Yvette, France.
Maxime Audin *Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, Gif-sur-Yvette, France.
Karine FréonInstitut Curie, PSL Research University, CNRS UMR 3348, INSERM U1278, Université Paris-Saclay, Equipe labellisée Ligue contre le Cancer, Orsay, France.ORCID 0000-0001-7853-078X
Jean-Pierre QuivyInstitut Curie, PSL Research University, CNRS, Sorbonne Université,CNRS UMR3664, Nuclear Dynamics Unit, Équipe Labellisée Ligue contre le Cancer, Paris, France.ORCID 0000-0001-6557-7204
Mehdi TachekortUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, Gif-sur-Yvette, France.
Elizabeth CesardUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, Gif-sur-Yvette, France.
Aurélien ThureauSynchrotron SOLEIL, HelioBio group, l'Orme des Merisiers, Saint-Aubin, France.
Virginie RoparsUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, Gif-sur-Yvette, France.
Paloma Fernández VarelaUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, Gif-sur-Yvette, France.
Gwenaelle MoalUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, Gif-sur-Yvette, France.
Ibrahim Soumana AdamouInstitut Curie, PSL Research University, CNRS UMR 3348, INSERM U1278, Université Paris-Saclay, Equipe labellisée Ligue contre le Cancer, Orsay, France.
Aleksandra UrygaInstitut Curie, PSL Research University, CNRS UMR 3348, INSERM U1278, Université Paris-Saclay, Equipe labellisée Ligue contre le Cancer, Orsay, France.
Pierre LegrandSynchrotron SOLEIL, HelioBio group, l'Orme des Merisiers, Saint-Aubin, France.
Jessica AndreaniUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, Gif-sur-Yvette, France.ORCID 0000-0003-4435-9093
Raphaël GueroisUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, Gif-sur-Yvette, France.ORCID 0000-0001-5294-2858
Geneviève AlmouzniInstitut Curie, PSL Research University, CNRS, Sorbonne Université,CNRS UMR3664, Nuclear Dynamics Unit, Équipe Labellisée Ligue contre le Cancer, Paris, France.
Sarah LambertInstitut Curie, PSL Research University, CNRS UMR 3348, INSERM U1278, Université Paris-Saclay, Equipe labellisée Ligue contre le Cancer, Orsay, France.ORCID 0000-0002-1403-3204
Francoise OchsenbeinUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, Gif-sur-Yvette, France.ORCID 0000-0002-9027-4384
Centre National de la Recherche Scientifique · FRUniversité Paris Sciences et Lettres · FR

Funding

Agence Nationale de la Recherche ANR-16-CE11-0028Agence Nationale de la Recherche ANR-20-CE18-0038Institut National Du Cancer 2016-1-PL BIO-03-CEA1Institut National Du Cancer 2016-1-PLBIO-03-ICR-1
6 · The paper itself

Abstract

Genome and epigenome integrity in eukaryotes depends on the proper coupling of histone deposition with DNA synthesis. This process relies on the evolutionary conserved histone chaperone CAF-1 for which the links between structure and functions are still a puzzle. While studies of the

Indexed as

HistonesSchizosaccharomycesDNANucleosomesProliferating Cell Nuclear AntigenSaccharomyces cerevisiaeScattering, Small AngleX-Ray DiffractionDNAHistonesNucleosomesProliferating Cell Nuclear Antigenepigeneticgenome integrityhistone chaperonemolecular biophysicsnmrNucleosome assemblysaxsS. pombestructural biology

Identifiers

PMID38376141
PMCPMC10942606
OpenAlexW4387869184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.